BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Monte Rosa Therapeutics, Inc. (GLUE)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Monte Rosa Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-01-31
6:43 pm
Purchase		 2025-01-24 13G Monte Rosa Therapeutics, Inc.
GLUE		 BIOTECHNOLOGY VALUE FUND L P 4,393,210
7.200%		 4,393,210increase
(New Position)		 Filing